Oncology providers’ perspectives on endocrine therapy prescribing and management

PURPOSE: Adjuvant endocrine therapy (ET) can reduce the risk of recurrence among females with hormone receptor-positive breast cancer. Overall, initiation and adherence to ET are suboptimal, though reasons are not well described. The study’s objective was to better understand ET decision making, pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheeler, Stephanie B, Roberts, Megan C, Bloom, Diane, Reeder-Hayes, Katherine E, Espada, Maya, Peppercorn, Jeffrey, Golin, Carol E, Earp, Jo Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053382/
https://www.ncbi.nlm.nih.gov/pubmed/27757021
http://dx.doi.org/10.2147/PPA.S95594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053382/
https://www.ncbi.nlm.nih.gov/pubmed/27757021
http://dx.doi.org/10.2147/PPA.S95594

Ejemplares similares